NPI Ventures

NPI Ventures was a venture capital firm that served as the technology investment arm of Nikko Principal Investments Limited, the European private equity division of Japan's Nikko Cordial Corporation. Active primarily during the mid-2000s, the firm specialized in early-stage and growth-capital investments in the life sciences, biotechnology, and healthcare sectors, with a strong focus on the United Kingdom. It was well-known for its strategic partnerships with university commercialization firms, such as Biofusion plc and Imperial Innovations, to fund and develop academic spin-outs. Notable portfolio companies included Thiakis, a developer of obesity treatments acquired by Wyeth, and deltaDOT, a provider of analytical technologies for the pharmaceutical industry. The firm is no longer active, having ceased operations following the restructuring of its parent organization and the broader financial shifts of the late 2000s.